Cargando…
An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in asciti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245209/ https://www.ncbi.nlm.nih.gov/pubmed/35773636 http://dx.doi.org/10.1186/s12887-022-03433-9 |
_version_ | 1784738698006364160 |
---|---|
author | Honar, Naser Nezamabadipour, Najmeh Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Ataollahi, Maryam Shakibazad, Nader Javaherizadeh, Hazhir |
author_facet | Honar, Naser Nezamabadipour, Najmeh Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Ataollahi, Maryam Shakibazad, Nader Javaherizadeh, Hazhir |
author_sort | Honar, Naser |
collection | PubMed |
description | BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in ascitic fluid in the diagnosis of ascitic fluid infection in children with liver cirrhosis. MATERIALS AND METHODS: In this cross-section study, 80 children with underlying liver disease who attended the Hepatology and Emergency Department in Shiraz University Hospitals were studied. All the patients were evaluated by a thorough history, clinical examination, laboratory investigations, diagnostic paracentesis with PMNLs count, and Calprotectin, which was measured in 1 mL ascitic fluid by ELISA. RESULTS: Thirty-five patients (43.75%) were diagnosed with ascitic fluid infection. Of these children 6 cases had positive ascitic fluid culture (SBP). Calprotectin was high in AFI patients with a statistically significant difference in AFI patients compared to non-AFI patients. The cut-off levels were 91.55 mg /L and the area under the curve was 0.971. So it can serve as a sensitive and specific diagnostic test for detection of AFI in children with underlying liver disease. CONCLUSION: Elevated ascitic calprotectin levels in cirrhotic patients are a diagnostic and reliable marker for the detection of AFI and are considered a surrogate marker for PMN. |
format | Online Article Text |
id | pubmed-9245209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92452092022-07-01 An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis Honar, Naser Nezamabadipour, Najmeh Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Ataollahi, Maryam Shakibazad, Nader Javaherizadeh, Hazhir BMC Pediatr Research BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in ascitic fluid in the diagnosis of ascitic fluid infection in children with liver cirrhosis. MATERIALS AND METHODS: In this cross-section study, 80 children with underlying liver disease who attended the Hepatology and Emergency Department in Shiraz University Hospitals were studied. All the patients were evaluated by a thorough history, clinical examination, laboratory investigations, diagnostic paracentesis with PMNLs count, and Calprotectin, which was measured in 1 mL ascitic fluid by ELISA. RESULTS: Thirty-five patients (43.75%) were diagnosed with ascitic fluid infection. Of these children 6 cases had positive ascitic fluid culture (SBP). Calprotectin was high in AFI patients with a statistically significant difference in AFI patients compared to non-AFI patients. The cut-off levels were 91.55 mg /L and the area under the curve was 0.971. So it can serve as a sensitive and specific diagnostic test for detection of AFI in children with underlying liver disease. CONCLUSION: Elevated ascitic calprotectin levels in cirrhotic patients are a diagnostic and reliable marker for the detection of AFI and are considered a surrogate marker for PMN. BioMed Central 2022-06-30 /pmc/articles/PMC9245209/ /pubmed/35773636 http://dx.doi.org/10.1186/s12887-022-03433-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Honar, Naser Nezamabadipour, Najmeh Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Ataollahi, Maryam Shakibazad, Nader Javaherizadeh, Hazhir An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title | An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title_full | An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title_fullStr | An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title_full_unstemmed | An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title_short | An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
title_sort | evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245209/ https://www.ncbi.nlm.nih.gov/pubmed/35773636 http://dx.doi.org/10.1186/s12887-022-03433-9 |
work_keys_str_mv | AT honarnaser anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT nezamabadipournajmeh anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT dehghaniseyedmohsen anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT haghighatmahmood anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT imaniehmohammadhadi anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT ataollahimaryam anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT shakibazadnader anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT javaherizadehhazhir anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT honarnaser evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT nezamabadipournajmeh evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT dehghaniseyedmohsen evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT haghighatmahmood evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT imaniehmohammadhadi evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT ataollahimaryam evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT shakibazadnader evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis AT javaherizadehhazhir evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis |